Trials / Terminated

TerminatedNCT00302861

A Study to Evaluate the Treatment of Previously Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL)

Phase 1/2 Study to Evaluate the Feasibility and Tolerability of Treatment of Previously Untreated B-CLL Chronic Lymphocytic Leukemia (B-CLL) Patients With Recombinant Idiotype Conjugated to KLH (Id-KLH) Administered With GM-CSF

Status: Terminated
Phase: Phase 1 / Phase 2
Study type: Interventional
Enrollment: 86 (planned)

Sponsor: Genitope Corporation · Industry
Sex: All
Age: 18 Years
Healthy volunteers: —

Summary

This is a multi-center, open-label, single arm Phase 1/2 study evaluating the feasibility, safety, and tolerability of a series of 16 immunizations of Id-KLH with GM-CSF in patients with previously untreated B-CLL. The length of the controlled portion of the study is two years. The study will be conducted at investigative sites in the United States.

Conditions

B-Cell Chronic Lymphocytic Leukemia

Interventions

Type	Name	Description
BIOLOGICAL	MyVax

Timeline

Start date: 2006-03-01
First posted: 2006-03-15
Last updated: 2008-03-18

Source: ClinicalTrials.gov record NCT00302861. Inclusion in this directory is not an endorsement.